To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency Ablation
Clinical trial NCT04417010 · UNKNOWN
Trial details
- NCT number
- NCT04417010
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-01
- Primary completion
- 2023-05-31
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.